Loading...
XSHE
002030
Market cap1.03bUSD
Jul 10, Last price  
5.11CNY
1D
3.02%
1Q
-14.41%
Jan 2017
-57.35%
IPO
373.15%
Name

Daan Gene Co Ltd

Chart & Performance

D1W1MN
XSHE:002030 chart
P/E
—
P/S
9.47
EPS
—
Div Yield, %
0.30%
Shrs. gr., 5y
0.01%
Rev. gr., 5y
-32.33%
Revenues
758m
-11.18%
172,538,691207,275,582239,204,077319,601,082369,967,649457,560,392582,692,342854,372,3221,086,153,4331,474,339,1011,612,560,4701,542,429,3441,478,663,1271,098,217,1585,341,209,6277,664,262,20112,046,135,0391,180,897,086853,024,339757,661,908
Net income
-744m
L-19.54%
28,741,86435,036,36634,939,43147,356,35656,452,72868,010,52690,165,004143,765,389153,055,524101,237,346106,685,50986,447,802101,582,98492,181,8492,449,090,1573,618,186,5675,412,341,072104,659,630-925,169,858-744,378,901
CFO
319m
+6.38%
30,086,3088,790,31428,969,05054,351,04878,992,10164,537,1633,371,97226,977,09540,377,289000392,378,50992,972,7132,514,511,5293,304,545,7844,154,852,483845,764,161300,332,716319,489,253
Dividend
Jun 14, 20240.015 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Daan Gene Co., Ltd. specializes in the research, development, manufacturing, and commercialization of clinical diagnostic reagents and instruments. The company's extensive product portfolio encompasses advanced solutions such as fluorescence quantitative PCR products, time-resolved series diagnostics, enzyme-linked immunoassay (EIA) kits, various diagnostic instruments, and specialized scientific research services. Beyond product offerings, the company extends its expertise to provide comprehensive medical examination and health management services. These encompass a wide range of offerings, from genetic susceptibility gene testing and tumor marker analysis to crucial cervical cancer screening and general routine physical examinations, alongside other personalized health support. Established in 2001, the company was originally known as Da An Gene Co., Ltd. of Sun Yat-Sen University. It is presently headquartered in Guangzhou, located in the People's Republic of China.
URL
https://www.daangene.com/
IPO date
Aug 09, 2004
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT